Simultaneous administration of lactulose and 51Cr-ethylenediaminetetraacetic acid. A test to distinguish colonic from small-intestinal permeability change
- PMID: 1411284
- DOI: 10.3109/00365529209011181
Simultaneous administration of lactulose and 51Cr-ethylenediaminetetraacetic acid. A test to distinguish colonic from small-intestinal permeability change
Abstract
In normal adults intestinal permeation of ingested 51Cr-ethylenediaminetetraacetic acid (EDTA) is greater than that of lactulose. This difference is abolished in patients with ileostomies, suggesting that it results from colonic permeation of 51Cr-EDTA, which, unlike lactulose, resists bacterial degradation. To investigate the effect of an increase in colonic permeability on absorption of the two molecules, lactulose (5 g) and 51Cr-EDTA (50 microCi) were given orally in isosmolar solution to 11 patients with colitis, and their 24-h urinary excretion measured. By comparison the effect of an increase in small-intestinal permeability induced by ingestion of a hyperosmolar solution (4240 mosm/l) was measured in 10 healthy adults. Hyperosmolar stress increased the 24-h urinary excretion of 51Cr-EDTA above the normal mean + 2 standard deviations (3.31%) in all 10 healthy subjects, and in all of these excretion of lactulose was also increased (greater than 1.06%). In contrast, although seven colitics had a urinary excretion of 51Cr-EDTA above the normal mean + 2 SD, in only two of these patients was recovery of lactulose increased. This suggests that simultaneous administration of lactulose and 51Cr-EDTA may enable permeability changes affecting the colon alone to be distinguished from those involving the small intestine.
Similar articles
-
Lactulose, 51Cr-labelled ethylenediaminetetra-acetate, L-rhamnose and polyethyleneglycol 400 [corrected] as probe markers for assessment in vivo of human intestinal permeability.Clin Sci (Lond). 1986 Jul;71(1):71-80. doi: 10.1042/cs0710071. Clin Sci (Lond). 1986. PMID: 3086024 Clinical Trial.
-
Comparison of four markers of intestinal permeability in control subjects and patients with coeliac disease.Scand J Gastroenterol. 1994 Jul;29(7):630-9. doi: 10.3109/00365529409092484. Scand J Gastroenterol. 1994. PMID: 7939400
-
Do non-steroidal anti-inflammatory drugs increase colonic permeability?Gut. 1991 Jan;32(1):66-9. doi: 10.1136/gut.32.1.66. Gut. 1991. PMID: 1899408 Free PMC article. Clinical Trial.
-
Intestinal permeability to [51Cr]EDTA in infectious diarrhea.Dig Dis Sci. 1993 Sep;38(9):1651-7. doi: 10.1007/BF01303174. Dig Dis Sci. 1993. PMID: 8359077 Review.
-
Intestinal permeability: an overview.Gastroenterology. 1995 May;108(5):1566-81. doi: 10.1016/0016-5085(95)90708-4. Gastroenterology. 1995. PMID: 7729650 Review.
Cited by
-
The Intestinal Barrier in Parkinson's Disease: Current State of Knowledge.J Parkinsons Dis. 2019;9(s2):S323-S329. doi: 10.3233/JPD-191707. J Parkinsons Dis. 2019. PMID: 31561386 Free PMC article. Review.
-
Assessing intestinal permeability in Crohn's disease patients using orally administered 52Cr-EDTA.PLoS One. 2019 Feb 7;14(2):e0211973. doi: 10.1371/journal.pone.0211973. eCollection 2019. PLoS One. 2019. PMID: 30730969 Free PMC article.
-
Intestinal permeability, leaky gut, and intestinal disorders.Curr Gastroenterol Rep. 1999 Oct;1(5):410-6. doi: 10.1007/s11894-999-0023-5. Curr Gastroenterol Rep. 1999. PMID: 10980980 Review.
-
Assessing the site of increased intestinal permeability in coeliac and inflammatory bowel disease.Gut. 1996 Jun;38(6):864-9. doi: 10.1136/gut.38.6.864. Gut. 1996. PMID: 8984025 Free PMC article.
-
Intestinal permeability and its association with the patient and disease characteristics in Crohn's disease.World J Gastroenterol. 2008 Mar 7;14(9):1399-405. doi: 10.3748/wjg.14.1399. World J Gastroenterol. 2008. PMID: 18322955 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources